FFA
PBYI icon

Frazier Financial Advisors’s Puma Biotechnology PBYI Stock Holding History

Frazier Financial Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17K Buy
+183
New +$1.18K ﹤0.01% 607

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Frazier Financial Advisors's PBYI Position: Q1 2026 in Review

Frazier Financial Advisors opened a new position in Puma Biotechnology (PBYI) in Q1 2026: 183 shares worth $1.17K. The stake represents ﹤0.01% of the portfolio and ranks #607 among its holdings.

157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

  • Frazier Financial Advisors held 183 shares of Puma Biotechnology worth $1.17K as of Q1 2026.
  • Puma Biotechnology was a new Frazier Financial Advisors position in Q1 2026.
  • Puma Biotechnology made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q1 2026, its #607 holding.
  • 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.